Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Other Accumulated Expenses (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Other Accumulated Expenses for 11 consecutive years, with $4.0 million as the latest value for Q3 2025.

  • Quarterly Other Accumulated Expenses rose 95.5% to $4.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Sep 2025, up 95.5% year-over-year, with the annual reading at $1.8 million for FY2024, 17.92% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $4.0 million at Xtant Medical Holdings, up from $3.8 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $4.2 million in Q1 2025, with the low at $800000.0 in Q2 2023.
  • Average Other Accumulated Expenses over 5 years is $1.7 million, with a median of $1.4 million recorded in 2021.
  • The sharpest move saw Other Accumulated Expenses tumbled 61.47% in 2021, then soared 213.05% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $1.2 million in 2021, then decreased by 11.42% to $1.0 million in 2022, then soared by 48.16% to $1.5 million in 2023, then grew by 17.92% to $1.8 million in 2024, then surged by 121.74% to $4.0 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $4.0 million, $3.8 million, and $4.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.